Back to Top Skip to main content Skip to sub-navigation

Foreign liaison officers bring new perspective to MHS

Image of three men talking to each other Foreign liaison officers fit into the U.S. National Defense Strategy as a way to reinforce partnerships with key allies. Col. Kai Schlolaut (far right), functions as a primary link between the German surgeon general LTG Dr. Ulrich Baumgärtner (center) and the U.S. Assistant Secretary of Defense for Health Affairs Thomas McCaffery. (Photo provided by Col. Kai Schlolaut)

Recommended Content:

Global Health Engagement | Coronavirus

As the Military Health System transforms, the Office of the Assistant Secretary of Defense for Health Affairs looks to its foreign liaison officers, or LNOs, to continue an exchange of medical information between the United States and international allies.

According to Dr. Chris Daniel, senior adviser for Global Health Engagement, these relationships expand provider skill sets and improve patient care overseas and in domestic military treatment facilities. Strengthening international partnerships is a department goal tied to improving military readiness.

“It is international engagement that provides us the benefits of increasing readiness and strengthening our partnerships,” said Daniel. “It's critically important that we work together to build our medical capacities and increase our interoperability. When we need help, we want our partners to be familiar with how our medical system works and know how to work with us.”

The LNOs fit into the U.S. National Defense Strategy to reinforce partnerships with key allies. Currently, there are five LNOs stationed at Defense Health Headquarters. Health Affairs hosts officers from Canada, the United Kingdom, and Germany. Additionally, the Army Office of the Surgeon General hosts two LNOs from France and Japan.

One of those officers is Col. (Dr.) Kai Schlolaut. As the German health foreign liaison officer to the Office of the Assistant Secretary of Defense Health Affairs, Schlolaut functions as a primary link between the German surgeon general, the U.S. Assistant Secretary of Defense for Health Affairs, and their staffs. Schlolaut uses extensive medical experience as an emergency medicine doctor and an anesthesiologist, as well as experience in command positions within the German military to liaise between the two countries. 

Image of man standing next to four flags
As the first German LNO assigned to the MHS, Col. Kai Schlolaut functions as a primary link between the German surgeon general, the U.S. Assistant Secretary of Defense for Health Affairs, and their staffs. (Photo provided by Col. Kai Schlolaut)

“Colonel Schlolaut is very well-spoken and well-connected. His ability to articulate on behalf of the German surgeon general has been invaluable,” Daniel continued.

One of those communication tactics is using “structured dialogue,” which helps both leaders within the U.S.-German relationship focus on relevant topics and come to sustainable solutions. The leaders and their staffs meet once a year to discuss achievements and plan for future objectives.

“Whenever military treatment facility leaders, project managers, or surgeons general change, we have a vision and objectives in place to not start all over,” Schlolaut explained.

Structured dialogue focuses on three areas: operational medicine, public health preventive medicine, and research and development. Schlolaut facilitated projects in each of these areas, improving interoperability by identifying joint training opportunities in tactical casualty combat care like Operation Bushmaster. German and U. S. participation in exercises like Combined Joint Atlantic Serpent improves interoperability through field medical practices while sharing equipment and protocols in a tactical training environment.

The two countries also share information on preventive medicine. Germany is currently assessing the potential threat of tick-borne encephalitis for U.S. military members stationed in Europe, providing the MHS with research and health surveillance data related to tick-borne encephalitis and other risks to U.S. troops.

“We're working closely together to reduce potential harm for deployed service members worldwide,” Schlolaut continued.

This threat includes the current COVID-19 pandemic, where Schlolaut’s role has shifted from organizing training opportunities to fostering collaboration between German and U.S. military researchers. The teams are delving into the genomics of the novel coronavirus. He also advises the German military community stationed in the U.S. on medical measures of protection and behavior in case of an infection.

As the first German LNO assigned to the MHS, Schlolaut feels privileged to set the pace for future LNOs.

“Having me here represents not only the long-lasting friendship that both of our military health systems have had, but also it's an expression of trust and partnership,” he explained. “Whether it’s through routine aspects like training exercises or in crisis situations like the current COVID-19 crisis, having a different perspective is always beneficial. For me personally, it's an honor to be here.”

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA-AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

Joint Pub 3-07, Stability Operations, September 29, 2011

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.